{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T11:31:22Z","timestamp":1780399882451,"version":"3.54.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.annder.2009.01.009","type":"journal-article","created":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T04:27:24Z","timestamp":1240547244000},"page":"407-411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Profil \u00e9volutif des patients atteints de pemphigo\u00efde bulleuse au cours de la premi\u00e8re ann\u00e9e de traitement"],"prefix":"10.1016","volume":"136","author":[{"given":"V.","family":"Doffoel-Hantz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sparsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Durox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-M.","family":"Bonnetblanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"B\u00e9dane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2009.01.009_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archderm.1995.01690130050009","article-title":"Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions","volume":"131","author":"Bernard","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2009.01.009_bib2","first-page":"4S1","article-title":"Incidence de la pemphigo\u00efde bulleuse","volume":"133","author":"Baricault","year":"2006","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2009.01.009_bib3","doi-asserted-by":"crossref","first-page":"a209","DOI":"10.1136\/bmj.a209","article-title":"Incidence of bullous pemphigoid and pemphigus vulgaris","volume":"337","author":"Joly","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.annder.2009.01.009_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000106574","article-title":"Neurological disorders in patients with bullous pemphigoid","volume":"215","author":"Cordel","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2009.01.009_bib5","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1001\/archderm.143.12.1536","article-title":"A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid","volume":"143","author":"Beissert","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2009.01.009_bib6","first-page":"751","article-title":"Pronostic vital de la pemphigo\u00efde bulleuse\u00a0: analyse d\u2019une cohorte de 78\u00a0malades","volume":"122","author":"Bernard","year":"1995","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2009.01.009_bib7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/archderm.134.4.465","article-title":"High risk of death in elderly patients with extensive bullous pemphigoid","volume":"134","author":"Roujeau","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2009.01.009_bib8","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jaad.2008.07.022","article-title":"Mortality of bullous pemphigoid: an evaluation of 223\u00a0patients and comparison with the mortality in the general population in the United States","volume":"59","author":"Parker","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2009.01.009_bib9","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1046\/j.1365-2133.1997.6581643.x","article-title":"Anti-BP180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: a cohort analysis of 94\u00a0elderly patients","volume":"136","author":"Bernard","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2009.01.009_bib10","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0190-9622(87)80227-X","article-title":"Blood eosinophilia as a severity marker for bullous pemphigoid","volume":"16","author":"Bernard","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2009.01.009_bib11","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/archderm.141.6.691","article-title":"Prediction of survival for patients with bullous pemphigoid: a prospective study","volume":"141","author":"Joly","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2009.01.009_bib12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","article-title":"A comparison of oral and topical corticosteroids in patients with bullous pemphigoid","volume":"346","author":"Joly","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2009.01.009_bib13","first-page":"4S3","article-title":"Comparaison de deux strat\u00e9gies th\u00e9rapeutiques de corticoth\u00e9rapie locale dans le traitement de la pemphigo\u00efde bulleuse","volume":"133","author":"Joly","year":"2006","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2009.01.009_bib14","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/archderm.134.9.1075","article-title":"Evaluation of clinical criteria for diagnosis of bullous pemphigoid","volume":"134","author":"Vaillant","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2009.01.009_bib15","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2133.2005.06662.x","article-title":"Annual incidence and mortality of bullous pemphigoid in the Grampian region of North-east Scotland","volume":"153","author":"Gudi","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2009.01.009_bib16","doi-asserted-by":"crossref","first-page":"a180","DOI":"10.1136\/bmj.a180","article-title":"Bullous pemphigoid and pemphigus vulgaris\u2013incidence and mortality in the UK: population-based cohort study","volume":"337","author":"Langan","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.annder.2009.01.009_bib17","unstructured":"Joly P, Roujeau JC, Benichou J, Delaporte E, D\u2019Incan M, Dreno B, et al. A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study. J Invest Dermatol, sous presse."},{"key":"10.1016\/j.annder.2009.01.009_bib18","first-page":"4","article-title":"Introducing a novel Autoimmune bullous skin disorder intensity score (ABSIS) in pemphigus","volume":"17","author":"Pfutze","year":"2007","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.annder.2009.01.009_bib19","first-page":"4S2","article-title":"La positivit\u00e9 de l\u2019immunofluorescence directe \u00e0 l\u2019arr\u00eat de la corticoth\u00e9rapie est le principal facteur pr\u00e9dictif de rechute de pemphigo\u00efde bulleuse","volume":"133","author":"Reguia\u00ef","year":"2006","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2009.01.009_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archdermatol.2007.9","article-title":"Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid","volume":"144","author":"Iwata","year":"2008","journal-title":"Arch Dermatol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963809000817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963809000817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:54:57Z","timestamp":1758970497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963809000817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0151963809000817"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2009.01.009","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Profil \u00e9volutif des patients atteints de pemphigo\u00efde bulleuse au cours de la premi\u00e8re ann\u00e9e de traitement","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2009.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Copyright \u00a9 2007 Elsevier Masson SAS. All rights reserved","name":"copyright","label":"Copyright"}]}}